Medical device company Adherium and informatics company Summatix are teaming up to help clinicians provide the best possible care for people with asthma and chronic obstructive pulmonary disease (COPD). Through this partnership, Adherium will gain access to Summatix’s regulated data platform…
News
Nuvaira, a medical device company, announced the upcoming publication of several scientific studies detailing the findings of clinical trials that assessed the safety and effectiveness of its Targeted Lung Denervation (TLD) therapy in patients with chronic obstructive pulmonary disease (COPD). Nuvaira’s proprietary TLD therapy works to disrupt pulmonary…
Air pollution can increase the risk of emphysema among people who have never smoked, a recent study has found. The study, titled “Association Between Long-term Exposure to Ambient Air Pollution and Change in Quantitatively Assessed Emphysema and Lung Function,” was published in the Journal of the…
Olympus‘ Spiration Valve System (SVS), a device that can be inserted into a patient’s airways to redirect air from diseased regions of the lungs and toward its healthier parts, improves respiration in people with severe emphysema, a clinical trial found. Its results were reported in the study, “…
Verona Pharma released additional results of a Phase 2 trial demonstrating that maintenance treatment with its dry powder inhaler (DPI) formulation of ensifentrine (RPL554) is safe, and significantly improves lung function in people with moderate to severe chronic obstructive pulmonary disease (COPD). The trial met all its primary…
Only a year ago, Florence Attaway — for decades a half-pack-a-day smoker — struggled to walk even one city block. “I had to take a taxi from my home one block to the hospital because I could hardly breathe,” said the 83-year-old New Yorker, who has chronic obstructive pulmonary…
Note: This is the third article in a series written in collaboration with respiratory therapist Mark W. Mangus Sr., RRT, RPFT, FAARC, and oxygen expert Ryan Diesem. This segment also includes contributions from Donna Frownfelter, PT, DPT, MA, CCS, RRT, FCCP, and Marion Mackles, PT, BS, LMT. The first two…
Having good heart and lung fitness in middle age reduces a person’s risk of developing, or dying, from chronic obstructive pulmonary disease (COPD), a new study shows. The results were published in the journal Thorax, in an article titled, “Midlife cardiorespiratory fitness and the long-term risk…
News
Walgreens ‘Find Care’ Program Expands Care Management to People with COPD, Asthma, and Diabetes
The drugstore company Walgreens has expanded its Find Care program to include chronic care management for people with diabetes, asthma, and chronic obstructive pulmonary disease (COPD). The expansion will include partnerships with device manufacturers to give patients access to tools that will help them better monitor their…
Viral respiratory infections, like those caused by a cold or flu, may particularly aggravate symptoms of chronic obstructive pulmonary disease (COPD), according to early data from a clinical trial testing the safety and effectiveness of SNG001, an inhaled interferon-beta therapy by Synairgen. These latest preliminary findings in the…
Recent Posts
- The value of tapping into COPD community resources
- Tozorakimab reduces COPD exacerbations in two large clinical trials
- Losing myself, finding myself: How recovery is harder with COPD
- Redrawing the geography of my life one breath at a time
- A diagnosis is a map that shows our way through an unknown land